• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Pediatrics

Cough medicine-related ED visits linked to unsupervised ingestion

byLeah Carr, MD
November 12, 2013
in Pediatrics, Public Health, Surgery
Reading Time: 4 mins read
Discharge diagnoses in the E.R. cannot retrospectively identify non-emergent visits
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. The proportion of emergency department (ED) visits due to adverse drug effects (ADEs) in young children from infant cough and cold medications (CCMs) compared to other medications has decreased since withdrawal and relabeling interventions in 2007 and 2008, respectively.


2. Following the 2008 label revisions, ADEs due to unsupervised ingestions of CCMs in children ages 2-3 years experienced a smaller decline (24%) than those due to supervised administration (54%). Similarly, ADEs due to unsupervised ingestions accounted for 64% and 88% of ADE ED visits after withdrawal and relabeling interventions, respectively.

Evidence Rating Level: 2 (Good)

Study Rundown: Adverse drug effects (ADEs) due to cough and cold medications (CCMs) have been associated with emergency department (ED) visits in children and even infant deaths. In light of these known risks, in 2007, over-the-counter (OTC) infant CCMs for children < 2 years old were withdrawn voluntarily. One year later, in 2008, CCM labels were revised to state that they should not be used in children < 4 years old. This study assessed whether these interventions were associated with changes in ED visits for CCM ADEs in children. Results indicated that the proportion of CCM-related ADEs have decreased since withdrawal and relabeling interventions in 2007 and 2008. However, ADEs due to unsupervised ingestions of CCMs in children ages 2-3 years experienced a smaller decline (24%) than those due to supervised administration (54%), following label revisions. Furthermore, ADEs due to unsupervised ingestions accounted for 64% and 88% of ADE ED visits after withdrawal and relabeling interventions, respectively. Data from this study do not include ADE cases that were not in the ED, which may have limited the results. Still, because CCM-related ED visits have not been completely eliminated, and because this study links unsupervised ingestions to most CCM ADEs, efforts must be made to limit young children’s access to medications, such as safer medication handling and storage in the home.

Click to read the study published today in Pediatrics

RELATED REPORTS

One Big Beautiful Bill could impact half of Medicaid beneficiaries

Patient values and preferences when treating acute episodic migraine

Relevant Reading: Toxicity of Over-the-Counter Cough and Cold Medications

Study Author, Dr. Lee Hampton, MD, talks to 2 Minute Medicine: Medical Officer, Division of Healthcare Quality Promotion, CDC.

“The 2007 withdrawal of over-the-counter infant cough and cold medications and the 2008 addition of a warning against use by young children to over-the-counter cough and cold medication packages were associated with reductions in emergency department visits for adverse events caused by these medications among young children, especially adverse events resulting from caregivers giving medications to children.  However, in recent years the vast majority of emergency department visits for cough and cold medication adverse events have been due to children getting into these medications when they were not supposed to.

Efforts to reduce cough and cold medication adverse events among children need to focus on preventing children from accessing such medications without supervision. Clinicians can help by counseling adults to keep medications up and away and out of sight, to properly lock child-resistant caps after every use, and to not give cough and cold medications to children <4 years old.”

In-Depth [retrospective analysis]: Data were collected from 58 general hospitals and 5 pediatric specialty hospitals as part of the National Electronic Injury Surveillance System-Cooperative ADE Surveillance (NEISS-CADES) project. ED visits by patients < 12 years of age who were seen for an ADE-related reason from January 1, 2004 to December 31, 2011 were considered for analysis. From there, cases were classified as either “unsupervised ingestions” that lacked adult supervision, or “supervised administrations,” those provided by a caregiver. Between 2004 and 2011, there were 61 168 CCM ADE-related ED visits involving children < 12 years of age, with CCMs being the only medication implicated in 93.4% of visits and OTC CCMs accounting for 76.6% of visits. Following the 2007 withdrawal of OTC infant CCMs, ED visits for CCM-induced ADEs for children < 2 years old decreased by 41% (difference in proportions: -1.7%, 95% CI: -2.7% to -0.6%). Specifically, ADE-related ED visits decreased by 55% for supervised administration (difference in proportions: -1.8%, 95% CI: -2.9% to -0.6%), while unsupervised ingestion ADEs did not decrease significantly. Similarly, following the 2008 relabeling intervention of CCMs, ED visits for ADEs for children ages 2 to 3 years decreased by 54% for supervised administration (difference in proportions: -2.9%, 95% CI: -5.4% to -0.5%), while unsupervised ingestions declined by only 24% (difference in proportions: -2.6%, 95% CI: -5.3% to -0.01%). ADEs due to unsupervised ingestions accounted for 64% and 88% of ADE ED visits after the withdrawal and relabeling interventions, respectively. Interrupted time series analysis revealed similar trends.

By Cordelia Y. Ross and Leah H. Carr

More from this author: Shared decision-making associated with increased parental resistance to vaccinations; AAP policy statement addresses influence of media on children; Pediatric gunshot injuries associated with higher mortality and costs; Psychotropic medication use declining in children with behavioral disorders; Postnatal breastfeeding concerns associated with discontinuation

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

 

 

 

 

 

Tags: adverse drug effectsingestionpolicy
Previous Post

Adjuvant misoprostol not associated with improvement in late second-trimester abortions

Next Post

The HAS-BLED score: Bleeding risk in atrial fibrillation [Classics Series]

RelatedReports

Clinical care collage: a smiling clinician in a white coat with a stethoscope around her neck beside a blank clipboard
Public Health

One Big Beautiful Bill could impact half of Medicaid beneficiaries

March 30, 2026
Migraine collage: a woman with her eyes closed and soft arcs radiating from her temple, a glass of water and a sleep mask
Neurology

Patient values and preferences when treating acute episodic migraine

March 26, 2025
Ophthalmology

Anti-VEGF therapy for retinopathy of prematurity may be associated with pulmonary hypertension risk

October 19, 2022
ACP offers recommendations to improve the ACA, patient care
Pediatrics

Supplemental nutrition sssistant programs may help prevent child maltreatment

August 16, 2022
Next Post

The HAS-BLED score: Bleeding risk in atrial fibrillation [Classics Series]

Vitamin and supplement data remains limited, may provide no benefit

Low brown fat may explain increased susceptibility to type 2 diabetes in south Asians

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways
  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.